Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The proposed study will use a factorial design to evaluate the most promising and accessible
behavioral and pharmacologic treatments aimed at achieving maximal efficacy for smoking
cessation among people living with HIV who smoke. The study will randomize 300 participants
people living with HIV , who smoke and who are receiving care in a methadone maintenance
program in Nairobi, Kenya to one of the following 4 conditions: (1) bupropion + Positively
Smoke Free (an 8 session tailored behavioral intervention for people living with HIV
smokers); (2) bupropion + Standard of Care (brief advice to quit); (3) Placebo + Positively
Smoke Free; and (4) Placebo + Standard of Care.
Phase:
Phase 3
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore